Osteoprotegerin is associated with mortality in kidney transplant recipients
Osteoprotegerin (OPG) is a secreted protein that affects bone turnover and is implicated in heart and kidney disease. A recent study identifies OPG as an independent risk factor for all-cause mortality in patients after kidney transplantation. 982 prevalent kidney transplant (KT) recipients were followed up for all-cause mortality for 6 years. The researchers observed that each 1 pmol/L higher-serum OPG level was associated with a 49% higher risk of mortality.
Biomedica´s OPG ELISA was used in this recent study and is part of our Clinical Nephrology Biomarker ELISA line of reliable and widely cited assays.
Check out the Biomedica OPG ELISA:
Reliable – validated according to international guidelines
Most referenced human OPG ELISA
Only 20µl sample volume required
Association between serum osteoprotegerin level and mortality in kidney transplant recipients. Gupta V et al., 2021. Transpl Int 19. doi: 10.1111/tri.13847. Epub ahead of print. PMID: 33606319